Development of subcutaneous abscesses due to Mycobacterium bovis following hepatitis and bacillus Calmette-Guerin
G Kafeel1, S H Qadri, S A Pasha
1Al-Noor Specialist Hospital, Makkah, and Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Abstract:
Vaccination to prevent hepatitis B and tuberculosis (TB) forms a part of the national immunization program in the Kingdom of Saudi Arabia. The hepatitis B vaccination was introduced in the Makkah region in January 1991G. Since then, 25 children have developed post vaccination subcutaneous abscesses at the site of vaccination. Microbiological studies proved these to be of bacillus Calmette-Guerin vaccine (BCG) origin. Ten patients were treated successfully with isoniazid (INH) and rifampicin and 15 with INH alone. Four patients required incision and drainage. Possible reasons for this complication in our patients are discussed.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Inhalation Anthrax
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:


